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Abstract. Biocatalysis has widened its scope and relevance since new molecular tools, including 18 
improved expression systems for proteins, protein and metabolic engineering, and rational techniques for 19 
immobilization, have become available. However, applications are still sometimes hampered by low 20 
productivity and difficulties in scaling up. A practical and reasonable step to improve the performances 21 
of biocatalysts (including both enzymes and whole-cell systems) is to use them in flow reactors. This 22 
review describes the state of the art on the design and use of biocatalysis in flow reactors. The 23 
encouraging successes of this enabling technology are critically discussed, highlighting new 24 
opportunities, problems to be solved and technological advances. 25 
 26 
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Biocatalysis in flow reactors: why? 27 
Bioprocesses (including biocatalysis) and continuous processing have been identified as the foremost 28 
key green research areas for sustainable manufacturing from pharmaceutical and fine chemicals 29 
industries [1]. Biocatalysis has widened its scope and application thanks to the massive advances in 30 
protein and metabolic engineering, together with biocatalyst immobilization [2]. The performances of a 31 
single enzyme can be improved in terms of substrate scope, operational stability and selectivity by 32 
advanced protein engineering, whereas biosynthetic pathways can be engineered in suitable microbial 33 
hosts leading to the preparation of molecules of different degree of complexity starting from cheap and 34 
largely available natural substrates (metabolic engineering). Biocatalysis is now a reliable tool to develop 35 
green and intensified processes, as long as proper reactor configurations are designed. Biocatalysis is 36 
customarily carried out in batch reactors, which are flexible and simple. However, biocatalysis in 37 
continuous flow reactors can be more productive, controlled and environmentally sustainable [3,4]. 38 
Specifically, flow chemistry (see Glossary) has rapidly developed both at industrial and academic level 39 
[5-8], encompassing the design of compact and reconfigurable manufacturing platform for the synthesis, 40 
and even formulation, of active pharmaceutical ingredients [9,10].  41 
The transition from batch to continuous flow micro- and meso-reactors involves other two key concepts 42 
of modern industrial biotechnology: green chemistry and process intensification (see Glossary) [11]. 43 
Flow processing has the potential to accelerate biotransformations due to enhanced mass transfer, making 44 
large-scale production more economically feasible in significantly smaller equipment with a substantial 45 
decrease in reaction time, from hours to a few minutes, and improvement in space-time yield, with 46 
increases of up to 650-fold as compared to batch processes. The small dimensions of the reactors 47 
facilitated control of the reaction parameters, which can result in improved yields and productivities [12]. 48 
Better process control makes the reaction more efficient and waste generation is minimized. The modular 49 
nature of flow reactors also enables for the flexible increase of production volume by simply numbering-50 
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up (putting flow reactors in series and/or parallel). Overall, these features result in reduced inventory, 51 
waste and energy requirements of the flow biocatalytic process, as compared to the conventional batch 52 
mode. Moreover, biocatalyst stability (Box 1) is enhanced by working in an environment where harsh 53 
mixing is avoided.  54 
Biocatalytic processes in continuous flow reactors have attracted attention in recent years for carrying 55 
out continuous manufacturing systems with high level of intensification; here, we discuss the most 56 
significant innovations, new developments, trends, and future directions. Unfortunately, lack of clarity 57 
concerning basic lexicon and definitions of this multidisciplinary field is often encountered. This review 58 
aims also to clearly define the terminology and definitions, which apply to this rapidly expanding field 59 
and to provide recommendations for reporting of biocatalytic reactions in flow reactors. 60 
 61 
Box 1. Biocatalyst stability 62 
A general concern when using a biocatalyst is its lifetime. Enzyme stability is typically affected by 63 
several factors, such as temperature, pH, surfactants, etc., which can disrupt the catalyst structural 64 
interactions. Immobilization is often used to enhance enzyme stability: it limits heat and mass transfer, 65 
minimizing access of destabilizing agents to the enzyme; moreover, immobilization onto a surface 66 
introduces additional interactions that stabilize the tertiary structure of the enzyme; and loss of quaternary 67 
structure can be minimized by cross-linking unbound subunits to those already bound to the support.  68 
In a batch operation, if immobilized enzyme is used, the biocatalyst can be recovered and reused. If 69 
needed, fresh biocatalyst can be added or/and the reaction time can be adjusted to maintain product 70 
quality. However, the amount of solid particles (biocatalysts) that batch reactor can handle is limited, 71 
and tuning of reaction time may impact downstream processes. In a flow reactor with immobilized 72 
enzymes in continuous operation, the temperature profile can be gradually increased to compensate for 73 
enzyme deactivation with increased reactivity, but a more practical approach consists of adjusting the 74 
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flow rate to the profile of enzyme deactivation, so that the quality of product concentration stays constant. 75 
A window of operation to evaluate the effective use of immobilized biocatalysts has been suggested 76 
based on the turnover number (tn), defined as the amount of product formed per amount of catalyst used 77 
[94,95]. Janssen and co-workers suggested that if the tn of a catalyst is too low, immobilization is not 78 
economically viable [94]. On the other hand, the tn may be very high, or the products may have high 79 
added value, resulting in catalyst costs under 0.05% of the added value. In this case, catalyst recycling is 80 
generally not justifiable. However, if a tn falls within these limits then enzyme immobilization is 81 
adequate. Additionally, the impact of catalyst costs on the product costs can be estimated based on the 82 
total turnover number (ttn), defined as the moles of product formed (or of substrate converted) per mole 83 
of catalyst employed. Accordingly, the ttn should exceed 1000 for high-value compounds produced at 84 
small scale, or 50000 for commodity goods [95]. The biocatalyst half-life (time required to reduce its 85 
activity to 50%) is a key parameter and can be determined under operational conditions [95]. Again, there 86 
is no gold standard for enzyme half-life, it is factored in the cost of the process. 87 
 88 
 89 
Working principles in of biocatalysis in flow reactors 90 
The market accessibility of automated and easy-to-control instrumentation for flow chemistry has 91 
increased in recent years, making controlled and reproducible work feasible. Different companies (e.g., 92 
Vapourtec Ltd, Corning, Syrris, ThalesNano Nantechnology Inc., Accendo Corporation, AM 93 
Technology, Uniqsis Ltd, Future Chemistry Holding BV, Chemtrix BV, Advion Inc., Ehrfeld, and YMC 94 
Co. Ltd) offer now modules for micro- and meso-fluidic flow chemistry at lab scale.  95 
The main components of a flow reactor for biocatalysis are schematically represented in Figure 1. The 96 
biocatalytic vessel can be a flow coil, a microfluidic device, a meso packed bed reactor (PBR, see 97 
Glossary), a membrane reactor or a wall-coated (surface immobilized) reactor. Mixing can be modulated 98 
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and placed at different points in the reactor, including at downstream of the reactor to aid product 99 
extraction. Heat and mass transfer can be accurately modulated by adjusting the material and size of the 100 
reactor. The outflowing stream can be analyzed in real-time [13]. Finally, in-line liquid-liquid extraction, 101 
solid adsorption, quenching, membrane separation, and solvent evaporation can be integrated with the 102 
biotransformation [14]. 103 
 104 
Figure 1 to be inserted here 105 
 106 
Biocatalysis in micro- and meso-reactors: types and definition 107 
Miniaturization is an important feature in flow chemistry and efficient micro- and meso-fluidic flow 108 
reactors are among the most important tools for the development of new and efficient continuous 109 
processes (Box 2). The opportunities and challenges for carrying out biocatalysis in microfluidic reactors 110 
have been previously reviewed [15]. Microreactors are often classified as either chip-type or microtube 111 
(microcapillary) devices [16,17]. Chip-type reactors usually have either a bankcard or microscope slide 112 
footprint with external dimensions not exceeding a few centimeters [18,19]. This allows for easy control 113 
of microfluidics and for the integration in a single device of more than one function or process, e.g., 114 
sensors and control units, upstream and/or downstream processes. The integration of downstream 115 
processes enables facilitated in-situ product recovery (ISPR) [20,21,22]. A microcapillary reactor simply 116 
uses a microchannel as the reaction space. It can be made of glass, plastic or metal, and it is often prepared 117 
using gas or liquid chromatography parts. Besides its simplicity, this type of microreactor can be easily 118 
scaled up by assembling together a bundle of microcapillaries [18,21]. 119 
  120 
Box 2. Microreactors and mesoreactors 121 
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Miniaturization for continuous flow reactors has been typically associated with devices displaying 122 
channels or tubes with internal diameters between 10 µm to a few mm [20,39,41,96]. This scale range 123 
can be divided to comprise microreactors (also called microfluidic reactors) and mesoreactors at a 124 
threshold corresponding to an inner diameter sized 500 µm. Microreactors have diameters under this 125 
threshold, displaying a volume in the µL range, and specific areas (area/volume) between 5000–50,000 126 
m2/m3, allowing: a) extremely effective heat and mass transfer; b) operation under low Reynolds number, 127 
corresponding to laminar flow, e.g., smooth and orderly, like thin sheets gliding over each other where 128 
mixing is diffusion-limited, and c) fast and effective temperature control. Dean vortices are created in 129 
the bends of the channels, which enhance mixing along the length of the microreactor. The small 130 
dimensions have a penalty, since throughput is limited and high pressure drops and channel blockage 131 
may occur [15,39,97,98]. Channel blocking due to the presence of solids, either as reaction products or 132 
non-solubilized starting materials, can be minimized through the use of ultrasounds, that applied in 133 
proper level of energy and frequency can disperse aggregates; or by introducing in the channel a solvent 134 
where the solid is soluble, that may dissolve a part of it [99,100].  135 
Mesoreactors have diameters sized between 500 µm and a few mm, corresponding to volumes in the mL 136 
range, and display specific areas between 100–10 000 m2/m3. Mesoreactors have higher flow capability 137 
and lower pressure drops but poorer heat transfer and diffusion-mixing features than microreactors. 138 
Moreover, for diameters exceeding 1 mm, high Reynolds numbers corresponding to turbulent flow, e.g., 139 
highly disordered and chaotic, with frequent fluctuations, such as eddies and vortices superimposed on 140 
the main motion are likely to result except at extremely low flow rates [20,39,96]. For diameters within 141 
500 µm and 1 mm, intermediate Reynolds numbers may occur, depending on the flow conditions. In this 142 
“grey” area of unpredictable flow, microfluidic behavior may be observed [20]. 143 
Mesoreactors are available with various designs to overcome the decreased mixing efficiency as 144 
compared to microreactors. Thus, mesoreactors may incorporate static mixing devices to cope with 145 
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mixing and back-mixing issues, such as Couette-Taylor devices to create vortices that induce a turbulent 146 
flow pattern or oscillatory baffled reactors, where a piston oscillates the flow to create eddies around 147 
each baffle, thus promoting turbulent mixing [41]. 148 
 149 
Either cell-free enzymes or whole cells can be used as biocatalysts. Immobilized enzyme reactors 150 
(IMERs) and free enzyme reactors (FERs) are the most common because cell-free systems offer 151 
advantages versus the whole-cell approach such as generally faster flow and lack drawbacks such as the 152 
additional barriers between the substrate(s) and the catalyst, the possibility of side reactions, and the need 153 
to maintain the cell wall integrity. Whole-cell biotransformations are particularly advantageous for co-154 
factor depending enzymes, as the presence of native metabolic pathways, as well as endogenous 155 
cofactors, can make these processes self-sufficient. Whole cells can be used in a tubular reactor (or in a 156 
back-mix reactor), but to avoid washout during continuous operation and simplify cell recycle and 157 
downstream processing they can be immobilized (immobilized whole cells reactors, IWCRs). A recent 158 
review by Polakovič and colleagues describes the use of immobilized whole cells in packed bed meso-159 
reactors and in micro-reactors [23]. Many applications regard immobilized whole cells with hydrolase 160 
activity, in particular in the field of biodiesel production [24]. In another recent application, the mycelium 161 
of C. cladosporioides MUT 5506, a strain endowed with transfructosylating activity, was used as alginate 162 
beads in an IWCR to produce a new mixture of fructooligosaccharides [25]. Whole cells of Aspergillus 163 
oryzae have also been used in a PWCR for the kinetic resolution (see Glossary) of flurbiprofen, in pure 164 
organic solvent [26].  165 
Flow reactors are often used with free biocatalysts (Configuration 1, Figure 2, Key Figure), but they can 166 
be successfully combined with immobilized biocatalysts, allowing for their repeated use and easing 167 
downstream processing. Different arrangements for immobilized reactors are used: i) biocatalyst 168 
immobilized on beads that are packed in the reactor, allowing for high enzyme load but being prone to 169 
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excessive back-pressure (Configuration 2, Figure 2) [27]; ii) biocatalyst immobilized on the inner surface 170 
of the channels (coated wall reactor) (Configuration 3, Figure 2) [28]; iii) biocatalyst immobilized on a 171 
monolith contained in the microchannel (Configuration 4, Figure 2) [15], which minimizes the limitation 172 
of configurations 2 and 3; iv) biocatalyst immobilized on a membrane (Configuration 5, Figure 2), as 173 
reviewed recently [29,30]. A number of immobilization techniques are nowadays available for either 174 
using packed immobilized biocatalysts, also including the innovative use of magnetic nanoparticles, 175 
[31,32] or for directly attaching enzymes onto the reactor surface, also exploiting tagged enzymes [33-176 
35]. Immobilization within the reactor allows to localize the enzyme in a microfluidic environment and 177 
to perform multienzymatic reactions where the sequential distribution of each enzyme across the 178 
structure of the reactor may be crucial to control the cascade reactions [36].  179 
 180 
Figure 2 (Key figure) to be inserted here 181 
 182 
An important issue of flow processes concerns their application on a large scale. For batch reactions, the 183 
scale has implications on the mass and heat transfer within the system, so the process conditions must 184 
often be re-optimized. Although scaling up microreactors for producing compounds at least at the gram 185 
scale seems simple on paper, the cost of individual microchip type reactors and the challenge of pumping 186 
liquid throughout the microreactors limit this approach. Larger mesoreactors can overcome these 187 
limitations, ultimately allowing for throughputs from g/h to tons/year. They may consist of scaled-up 188 
versions of the planar chip-type microreactor, single tubular reactors or parallel capillary reactors [37-189 
40]. The amount of product generated is determined by the duration over which the entire flow regime 190 
is operated, once flow rates and reactor volumes are defined. 191 
Flow in micro- and meso-reactors can occur in either monophasic flow or in slug flow (also known as 192 
segmented flow or Taylor flow), where two immiscible phases are present, producing discrete droplets 193 
9 
 
of solution (Figure 2, Configurations 6-9). Recirculation occurs within segments of the two-phase 194 
segmented flow, enabling a large surface area to be exposed to the second phase at any given time. By 195 
varying the relative flow rates of each stream, the size and periodicity of the slugs can be modulated and 196 
controlled. Slug-flow is often favored in mesoreactors to overcome back-mixing [41]. Bolivar and 197 
Nidetzky previously discussed key critical issues (e.g., critical mixing, possible blockage, phase 198 
separation), re-dimensioning multiphase flow reaction performance and gave guidelines to design 199 
scalable multiphase biocatalytic microreactors [28].  200 
Further knowledge about flow behavior in flow reactors can be obtained by using computational fluid 201 
dynamics (CFD), a tool that combines momentum, mass and heat transfer equations in complex 202 
geometries. CFD can theoretically evaluate the performance of flow reactors. Simulations can be 203 
compared with experimental data to provide relevant information on process conditions, such as the rate 204 
of substrate transport and how it is affected by channel geometry, the flow conditions and the physical 205 
properties of the fluid, to ultimately optimize the flow conditions and reactor configuration [29,42,43]. 206 
Analytical techniques (e.g., liquid and gas chromatography and mass spectroscopy) have been interfaced 207 
with flow systems to provide real-time reaction monitoring [44]. Integrating sensors to monitor variable 208 
process conditions (e.g., temperature, pH, dissolved oxygen, concentration of molecules) represents an 209 
important research topic; optical sensors, able to operate on-line or at-line, are particularly attractive, 210 
given their non-invasive, non-destructive nature, and footprint compatible with microfluidic devices [45]. 211 
In reactions where some parameters (such as oxygen or pH) can change, on-line monitoring is preferable, 212 
as it provides a direct measure of the progress of the reaction. This issue was recently successfully 213 
addressed by Gruber and colleagues, who used an optical pH sensor layer integrated in a microfluidic 214 
side-entry reactor to measure the pH at multiple points in narrow channels. This sensor could map the 215 
progression of a transketolase- and a penicillin G acylase-catalyzed reaction and constantly adjust the pH 216 
in the enzymatic reaction [46]. 217 
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Finally, essential information about the bioreactor is required to reproduce and understand the results of 218 
biocatalytic processes in flow reactors (see Box 3). 219 
 220 
Box 3. Reporting of biocatalytic reactions in flow reactors 221 
Key parameters need to be properly reported to reproduce and compare the performance of 222 
biotransformation in flow reactors (Table I).  223 
Table I. Key parameters of biocatalytic reactions in flow reactors. 224 
Parameter Information required 
Reaction time, determined by 
the time the reagents take to 
flow through the reactor. 
Residence time (t); tracer experiments can be performed to determine 
the residence-time distribution function 
Specific reaction rates (see below) 
Substrate concentration Concentration of the substrates ingoing the reactors; stoichiometric 
ratios must be specified 
Biocatalyst loading Amount of biocatalyst used (mg or g of immobilized biocatalysts) and 
activity (U) at zero time 
Reactor size Available reactor volume; the dimension of the channels should be 
specified as well as the void volume (or total porosity, i.e., void 
volume/geometric volume) for packed-bed and monolith reactors 
Reactor productivity Space-time yield normalized by the reactor volume 
Reactor stability Conversion at different times of operation (observed at optimal t) 
Biocatalyst productivity Amount of product synthesized per amount of enzyme used. This 
information can be expressed as ttn, measured as the quotient of the 
kcat (apparent turnover number) and the kd (first-order deactivation rate 
constant), both measured at the same temperature [101]. 
 225 
Specific reaction rates in continuous-flow systems (rflow) are generally calculated using the equation [90] 226 
rflow = [P] ×
f
mbiocatalyst
 227 
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where [P] is the product concentration flowing out of the reactor (commonly expressed as mmol mL-1), 228 
f is the liquid flow rate (commonly expressed as mL min-1), and mbiocatalyst [g] is the amount of biocatalyst 229 
loaded in the column. Alternatively, the amount of biocatalyst can be replaced by its activity. Rigorous 230 
comparison between the rates of batch and continuous-flow biotransformations cannot be made, since 231 
the reaction rate is dependent on substrate/product concentrations. A major advantage of continuous 232 
processes is that they can be modulated through residence times so that the flow stream leaving the 233 
reactor contains a constant concentration of substrate/product; thus, different rates can be compared only 234 
at similar degree of conversions. Good examples are kinetic resolutions, where the desired degree of 235 
conversion of a racemic mixture is around 50%, therefore, a batch and flow reaction can be compared by 236 
evaluating the time (for batch biotransformations) and residence time (for flow biotransformations) 237 
necessary to reach this conversion.  238 
 239 
Biocatalysis in flow reactors: selected examples 240 
Hydrolases 241 
Many examples of hydrolases, mainly lipases, can be found in the literature; reports from 1991 to 2013 242 
have been previously reviewed [47,48]. Here, we review applications that bring significant innovation to 243 
the field.  244 
Two-liquid phase systems consisting of water and a water-immiscible organic solvent are often used in 245 
biocatalysis to convert water-insoluble reactants, favoring the equilibrium of the reaction, and helping 246 
product recovery. Controlling liquid-liquid flow regimes in microchannels may provide large specific 247 
interfacial area: the formation of micro-droplets of hydrophobic organic solvents in water may allow for 248 
improved enzymatic activity in a continuous dispersed regime phase. Novak and colleagues described a 249 
microfluidic reactor integrated with a membrane separator for the preparation of isoamyl acetate, 250 
catalyzed by free Candida antarctica lipase B; optimizing the flow regime produced n-heptane droplets 251 
12 
 
in the aqueous phase containing the enzyme, furnishing a dramatic increase in the overall productivity 252 
[49]. The in-line liquid-liquid separation permitted product recovery in the organic phase and the reuse 253 
of biocatalyst for several consecutive biotransformations. 254 
A new concept called flow Pickering emulsion involves compartmentalizing a biocatalyst in water 255 
droplets (based on a water-in oil Pickering emulsion). The organic phase flows at the interface of the 256 
droplet, promoting catalysis with a 10-fold improved efficiency when compared to a batch process [50]. 257 
Ionic liquids have also raised interest as enzyme stabilisers, and they have been used in continuous liquid-258 
liquid conditions where the substrates are dissolved in a non-polar phase immiscible with the enzyme-259 
containing ionic liquids. This method has been applied to lipases for the synthesis of chiral esters and 260 
amides in flow with high turnover numbers and space-time yields with respect to batch [51,52]. Covalent 261 
and non-covalent immobilization for a β-glucosidase has been reported for thin film continuous flow 262 
processing; this technique requires a minimal amount of enzyme and relies on the large surface area 263 
available for efficient biotransformation [53]. Britton and colleagues devised an interesting system where 264 
different enzymes can be rapidly segregated through a metal coordinating poly-histidine tag in a 265 
continuous-flow, vortex fluidic device (VFD). The approach allowed the formation of distinct thin-layer 266 
enzymatic zones for multi-step biocatalysis, which the authors exemplified by combining an alkaline 267 
phosphatase and phosphodiesterase in sequence for the two-step hydrolysis of bis(p-268 
nitrophenol)phosphate into p-nitrophenol phosphate [54]. Another important development is the 269 
evolution of flow systems with increased complexity, such as the dynamic kinetic resolution of a 270 
protected amino acid derivative (N-Boc-phenylalanine thioethyl ester) in continuous flow, mediated by 271 
an alcalase, exploiting an alternating cascade of PBR and racemization reactors [55]. One advantage of 272 
the flow mode was that the biocatalyst proved to be more stereoselective than in the batch mode by 273 
minimizing the non-catalyzed reaction of benzylamine with the starting thioester, and the overall reaction 274 
was strongly accelerated. A three-enzyme cascade capillary monolithic bioreactor consisting of an 275 
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immobilized deoxyribonuclease I, a snake venom phosphodiesterase, and an alkaline phosphatase, was 276 
recently reported to efficiently digest genomic DNA into single nucleosides [56]. Finally, a first 277 
application of a micro- reactor based platform to study enzymatic polymerization reactions in continuous 278 
flow mode was reported by Kundu and colleagues [57]; a versatile microreactor design enabled enzyme-279 
catalyzed ring-opening polymerization of ε-caprolactone to polycaprolactone in continuous mode, in 280 
organic media, and at elevated temperatures. 281 
 282 
Transferases 283 
Using transaminases (TAs) in flow is very appealing because these enzymes are of great interest in 284 
pharmaceuticals. However, using cofactor-dependent enzymes under flow conditions is much more 285 
challenging. Interestingly, only a few examples of TAs in flow have been reported to date. Recombinant 286 
E. coli containing (R)-selective TAs were immobilized in a flow reactor; moderate residence times, clean 287 
production, and high biocatalyst stability were observed [58]. A cell-free TA from H. elongata, 288 
covalently immobilized on epoxy resin, proved to be very stable in a PBR at high flow rate for the 289 
synthesis of amines, purified in-line	through a basification followed by extraction with EtOAc [59]. By 290 
tuning the reaction conditions, the same enzyme could be used for the mild oxidation of a large range of 291 
amines with excellent conversion yields [60]. Lentikats have also been shown to be valid alternatives for 292 
TAs in flow [61], as have silica monoliths, onto which the enzymes can be covalently attached [62]. 293 
Monoliths are particularly appropriate for designing continuous flow reactions, in particular because they 294 
exhibit high void fractions to minimize pressure drop (see Glossary)[28,63,64].  295 
Transketolases (TKs) have also been reported in flow systems; one example describes the combination 296 
of a TK and a TA in sequential PBRs for the synthesis of 2-amino-1,3,4-butanetriol from 297 
hydroxypyruvate and glycolaldehyde. However, this setup used metal coordination, and the applicable 298 
flow was extremely low (between 2 and 30 µL/min). The enzymatic efficiency was lost within two weeks 299 
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for the TK, while the selected TA was almost completely inactive within 5 days [65]. A biocatalytic 300 
microfluidic multi-input reactor was developed using a soluble transketolase to address the limitations 301 
of single-point feeding [66]. With this strategy, an 8-fold improvement of productivity was obtained over 302 
fed-batch microplate reactions, an approach used to counter enzyme inhibition at high substrate 303 
concentrations. 304 
The use of a cyclodextrin glycosyltransferase cross-linked to chitosan spheres in a PBR was reported for 305 
the production of β-cyclodextrin from renewable materials. The microfluidic enzymatic system resulted 306 
in high operational stability without loss of activity after 100 h of continuous use [67].  307 
 308 
Lyases 309 
Ammonia lyases have been of interest for their potential use in the synthesis of cinnamic acid derivatives 310 
and non-natural amino acids. Until recently, the immobilization of cell-free catalysts had been limited to 311 
methodologies that are poorly suitable for flow, such as cross-linked enzyme aggregates (CLEAs) and 312 
microcapsule entrapment. A phenylalanine ammonia lyase (PAL) was immobilized on carboxylated 313 
single-walled carbon nanotubes, but the performance of the catalyst in flow was stable only for 72 h [68]. 314 
The same enzyme was immobilized on magnetic nanoparticles and used in a Magne-Chip microfluidic 315 
reactor, where the enzyme was efficiently used for substrate screening [69]. Brahma and colleagues 316 
reported on the safe handling of HCN in flow for the synthesis of cyanohydrines mediated by 317 
hydroxynitrile lyase (HNL) from Arabidopsis thaliana in a telescoped two-step biotransformation 318 
combining CalB and HNL [70]. 319 
A flow enzymatic cascade with three different immobilized enzymes was developed to synthesize 320 
complex chiral carbohydrate analogues from aldehydes and dihydroxyacetone in the presence of 321 
pyrophosphate [71]. This configuration could shift the equilibrium of the aldolase-catalyzed 322 
transformation reaction towards the synthesis of the carbohydrates, eliminating retroaldol reactions and 323 
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affording the desired products with high yields and stereochemistry dependent on the aldolase employed. 324 
Flow reactors appear particularly suited for assisting the conditions in which enzymatic cascade reactions 325 
can efficiently take place; namely, favourable thermodynamics, controlled kinetics and high selectivity.  326 
 327 
Oxidoreductases 328 
Oxidoreductases are industrially relevant enzymes, however they rely on cofactors which are expensive 329 
and often not spontaneously regenerated in the catalytic cycle, a crucial issue to consider when employing 330 
these enzymes in flow reactors [72]. Šalić and Zelić assembled two microreactors where an alcohol 331 
dehydrogenase was used to oxidize n-hexanol in the first reactor with the concomitant reduction of 332 
NADH, whereas the second reactor was used for the recycling of the cofactor through reduction of 333 
acetaldehyde catalyzed by the same enzyme [73].  334 
Co-immobilizing enzymes can assemble a coupled enzymatic system that specifically addresses the 335 
cofactor regeneration in close proximity and within the same bioreactor; Dall’Oglio and colleagues 336 
reported the efficient enantioselective reduction of bulky ketones in flow by combining a ketoreductase 337 
from P. glucozyma with a glucose dehydrogenase, which were compatible under the selected working 338 
conditions and catalytically active for several weeks despite the presence of 20% DMSO in the buffer 339 
[74]. An immobilized ketoreductase (P1B2 from Codexis) was used in a plug flow reactor (PFR, see 340 
Glossary) for the preparation of various chiral alcohols; the immobilized enzyme is highly active and 341 
stable in organic solvents, thus greatly simplifying product recovery [75-77]. An example of co-342 
immobilization of both enzyme and cofactor was developed by Lopez-Gallego and co-workers where 343 
they successfully trapped NAD+ (as well as FAD and PLP) in the same solid phase where the enzyme 344 
was immobilized. The cofactor remained available for catalysis and exogenous supplementation was no 345 
longer required [78]. 346 
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Efficient O2 -liquid transfer is required in bio-oxidation: this can be achieved in conventional batch 347 
reactors by high levels of aeration (also by using O2-enriched air) and agitation. However, scaling up 348 
gas/liquid reactions in batch reactors is critical because when size of the reactor increases, maintaining a 349 
uniform gas/liquid dispersion, and efficient distribution of mixing energy is problematic. Biocatalyzed 350 
flow reactions can address the scale constraints of batch reactors. Among the developed multiphasic flow 351 
reactor configurations, tube-in-tube reactors and segmented-flow proved more efficient for gas-liquid 352 
transfer [79,80]. In a tube-in-tube reactor, a pressurized gas permeates through a Teflon AF-2400 353 
membrane and reacts with the substrate in the presence of biocatalyst in liquid phase. Slug-flow reactors 354 
have been operated for the oxidation of (R)-limonene to (R)-perillic acid (using both wild-type 355 
Pseudomonas putida and recombinant P. taiwanensis VLB120) and for the stereoselective oxidation of 356 
achiral 1,3-diols with immobilized Acetobacter aceti [81,82]. In both the cases, poor oxidation was 357 
observed without gas-transferring devices. Recently, an automated tube-in-tube flow reactor system was 358 
developed for fast determination of the kinetics of oxygen-dependent enzymes [83]. 359 
A multiphase gas/liquid reaction also containing solids in the form of live cells and organic debris was 360 
successfully scaled up to 10 L using a dynamically mixed flow reactor, which avoided the accumulation 361 
of solids and blockage of the system [12,84]. This resulted in reduced cost of capital equipment, lower 362 
operating costs, and reduced catalyst consumption, due to faster throughput, for manufacturing processes. 363 
Finally, Table 1 reports selected examples of biocatalyzed flow reactions. 364 
 365 
Table 1 to be inserted here 366 
 367 
Concluding Remarks and Future Perspectives 368 
Recently, Sheldon and Pereira introduced the concept of “biocatalysis engineering”, which combines and 369 
entails the “engineering” of the different elements composing a biocatalytic process as a whole [91]. A 370 
17 
 
holistic approach, which integrates substrate engineering, medium engineering, protein engineering, 371 
metabolic engineering, immobilization engineering, biocatalytic cascade engineering, and reactor 372 
engineering should be considered for developing and optimizing biotransformations. In this context, this 373 
review shows that biocatalytic processes may be dramatically improved by continuous flow processing 374 
in both micro- and macro-structured reactors. Continuous manufacturing systems are particularly suited 375 
for making biocatalysis truly competitive with established preparative chemical methods. Many 376 
biocatalytic processes are carried out under heterogeneous conditions (immobilized biocatalyst, whole 377 
cells, liquid-liquid or liquid-gas systems): improved mixing efficiency achievable in flow reactors 378 
translates into improved mass transfer, consequently accelerating the overall process. The possibility to 379 
work in an environment where the biocatalyst suffers limited damages (controlled substrate 380 
concentration, continuous product removal, no mechanical stirring, highly overseen pressure and 381 
temperature) may lead to important increases in turnover number and frequency. Integrated processing 382 
and analytical control are easily realizable even on the microscale, facilitating progressive scale-up.  383 
Moreover, the possibility to perform in-line work-ups or purification procedures aimed at isolating the 384 
sole pure product represents great potential for continuous flow processes. As most of the cost of 385 
manufacturing of a biotech process is attributed to the downstream processing, such advancement 386 
answers the need to circumvent this constraint typically associated to in-batch biotransformations. In-387 
line purifications have been reported relying on extractions, catch and release strategies, use of 388 
scavengers or semi-preparative HPLC [26,89,92]. Integrated reaction and purification in microfluidic 389 
environment has been implemented for the complex cell free synthesis of protein, paving the way for the 390 
production of therapeutic proteins on location where required [93].  391 
However, efficient membrane separators or suitable solid adsorbents still need to be developed to 392 
simplify recovery and purification of the products or reutilization of the biocatalyst, avoiding tedious and 393 
material-consuming downstream operations. On-line monitoring still remains one of the key 394 
18 
 
development needs for flow bioreactors, alongside strategies to handle slurries, which often lead to 395 
clogging. Moreover, the complexity of multi-enzymatic systems, and how to individually optimize 396 
reaction conditions for maximum throughput and process efficiency in flow, remain challenging (see 397 
Outstanding Questions). New approaches such as printing of customized 3D reactor device could 398 
facilitate these developments.  399 
Therefore, further research on these issues is not only of interest for analytical and synthetic enzymatic 400 
reactions, enzyme stability studies or bioprocess development, but for a variety of biotechnological 401 
applications where continuous flow reactors can be envisioned. We feel there is a bright future for 402 
biocatalysis in flow reactors, with a number of biotransformations that may benefit from this approach 403 
towards more sustainable, greener production processes, possibly including modular and compact 404 
platforms up to production scale. 405 
 406 
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Table 1. Selected examples of biocatayzed flow reactions 626 
29 
 
Biotransformation Reactor 
configuration 
and volume 
Comments Ref 
Hydrolases    
 
IMER, packed bed 
0.82 mL 
Productivities and 
space-time yields 
exceeding values for 
batch reactions by a 
factor of 3100 and 40 
41 
 
IMER, packed 
bed, alternated 
with racemization 
columns 
0.82 mL  
 
Dynamic kinetic 
resolution; side 
reactions suppressed; 
enhanced 
productivity and 
overall acceleration 
45 
 
FER, microfluidic 
connected with a 
l/l separator 
0.50 mL 
High productivity, 
flow regime of 
dispersed organic 
phase/water droplets 
with in situ extraction 
of product and 
enzyme recycling 
39 
 
IMER, packed bed 
0.52 mL 
Enzyme-catalyzed 
polymerization in 
continuous mode; 
faster product 
formation compared 
to batch reactors 
46 
 
IMER, micro- and 
multi-channel, 
wall coated 
24.5 µL 
Space-time yield of 
500 mg glucose mL-1 
h-1 (conversion 70%); 
Half-life of 15 days 
under the operational 
conditions.  
86 
+
NH2
CaLB
tolueneR' O
O
NHCOR
R
S
HN
Boc
O
Alcalase
PhCH2NH2/DBU
tert-amyl alcohol
N
H
HN
Boc
O
OH + Ac2O
CaLB
water/n-heptane
O
O
CaLB = Candida antarctica lipase B
OO CaLB
toluene
CaLB = Candida antarctica lipase B
H O O H
O
n
lactose glucose  +  galactoseβ-galactosidase
30 
 
 
IMER, capillary 
wall-coated 
0.45 mL 
Residence time of 
48.8 min, full 
conversion for 20 
days 
87 
 
IMER, packed bed 
0.82 mL 
High productivity, 
overall acceleration 
90 
 
IMER, hybrid 
monolithic 2.49 
mL 
Improved biocatalyst 
productivity and 
space time yield 
41 
 
IMER, packed 
bed, sandwich-
like microchannel 
structure 
0.40 mL 
Almost complete 
conversion (99.5%), 
with overall enhanced 
acceleration 
42 
 
IWCR, packed 
bed 
3.50 mL 
Improved 
enantioselectivity, 
overall acceleration, 
integrated with in-
line product recovery; 
inline racemization of 
the unreacted 
substrate  
24 
Transferases    
 
IMER, micro-
channel, wall 
coated 
24.5 µL 
Space-time yields of 
500 mmol L−1 h−1 at 
product titers of ∼200 
mM. Operational 
half-life of about 10 
days. 
 
85 
 
WCIR, packed 
bed with inline 
recovery 
0.50 mL 
Reaction in MTBE: 
no leaching of PLP 
from the cells; high 
47 
sucrose glucose  +  fructoseinvertase
lipases
organic solventsR R'
OH
R R'
OCOR''
R'' O
O
R'''+ +   R'''OH
lipases
ionic liquidsR R'
OH
R R'
OCOR''
R'' O
O
R'''+ +   R'''OH
ROH + CaLB
[Bmim][Tf2N]
COOH
OH
HO
COOR
OH
HO
CaLB = Candida antarctica lipase B
F
COOH A. oryzae
EtOH
n-heptane F
COOEt
sucrose SPase + glycerol
fructose
SPase = sucrose phosphorylase
OHO
HO
OOH
OH
OH
HO
immobilized E. coli 
containing ω-transaminase/PLP
O
O
R
NH2
O
R
in MTBE
31 
 
enzyme stability 
(several days) 
 
IMER, micro-
channel packed 
bed 
18.4 µL-3.2 mL 
>80% activity 
retained after 21 days 
50 
 
IMER, packed 
bed, inline 
recovery 
0.9 mL 
Low residence times, 
high conversions; in-
line product recovery 
(ion exchange 
column)  
48 
 
IMER, packed 
bed, inline 
recovery  
0.9 mL 
Low residence 
times/high 
conversions; in-line 
product recovery 
(liquid/liquid 
extraction)  
49 
 
FER, microfluidic 
T-junction reactor 
60 µL 
 
Inline filtration 
device; complete 
conversion; 8-fold 
improvement of 
productivity over fed-
batch bioconversion 
55 
 
IMER, packed bed 
0.830 mL 
Bioconversion 
coupled with product 
purification; high 
yields = 52–89% 
within low t, high 
biocatalyst stability 
89 
 
IMER, packed bed 
13.5 mL 
Biocatalyst maintained 
100% operational 
stability after 100 h of 
continuous use; 
productivity of 310 g/L 
h with flow rate of 
5mL/min.  
56 
Lyases    
NH2
ω-transaminase
PLP
O
ω-transaminase
PLP
R-CHO RCH2NH2
ω-transaminase
PLP
ArCH2NH2 Ar-CHO
R O
H
LiO OH
O
O
+ transketolase R OH
OH
O
Mg2+, ThDP
O
HO
HO OH
B1
B2
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IMER; 
carboxylated 
single-walled 
carbon nanotubes 
0.2 mL 
No loss of activity 
over 72 h up to 60 
°C; enhanced overall 
productivity and 
acceleration 
57 
Oxidoreductases    
 
IMER, micro-
channel, wall 
coated 
13 µL 
operational half-life 
of the immobilized 
oxidase was 40 h. 
66 
 
IMER, packed bed  
0.90 mL 
High biocatalyst 
productivity, high 
stability in the 
presence of 20% 
DMSO 
63 
 
IMER, plug flow 
reactor  
5 mL 
High biocatalyst 
productivity, high 
stability and activity 
using IPA/water 9/1 
as medium 
64 
 
WCIR, catalytic 
biofilms with 
segmented air-
liquid flow 
0.31 mL 
Max. volumetric 
productivity 33.8 g L-
1 d-Operation time 12 
h 
68 
 
WCIR, packed 
bed with 
segmented air-
liquid flow 
5.1 mL 
Low t (10 min) for 
reaching total 
conversion; recovery 
inline by catch-and-
release strategy using 
a ion-exchange resin 
69 
Synthases    
S COOH S COOH
NH2PAL + NH3
PAL = Phenylalanine ammonia-lyase
S COOH
NH2
DAAO, O2
catalase
S COOH
O
DAAO = D-aminoacid oxidase
R R'
O
R R'
OHketoreductase
GDH
R R'
O
R R'
OHketoreductase
IPA/water 9/1
various Pseudomonas 
whole cells
COOH
Acetobacter aceti 
whole cells
OHHO OHHO
O
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  628 
 
FER, 
water/pentane 
segmented flow in 
capillary tubes 
2 mL 
Water/organic 
segmented flow 
allows high mass-
transfer rate without 
enzyme deactivation, 
leading to high yields 
88 
Cascade reactions    
 
Sequential two 
packed bed IMER  
1.5 mL each 
Transaminase loading 
was much higher than 
transketolase due to 
low amination rate: 
matching enzyme 
loading allowed to 
optimize the dual-
step enzyme reaction. 
 
54 
 
Sequential two packed 
bed IMER 
0.52 mL (PhON); 2.50 
mL (PhON+aldolase) 
The two sequential 
reactors allowed for 
favorable 
thermodynamics, 
controlled kinetics 
and high selectivity. 
60 
 
Sequential two packed 
bed IMER 
0.70 mL (CalB); 0.35 
mL (AtHNL) 
Acceleration of the 
reaction time over the 
batch protocols (40 
min vs 345 min); safe 
generation in situ of 
HCN.  
 
59 
P
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AS = aristocholene synthase 
ADS = amorphadiene synthase
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PhoN-Sf: acid phosphatase 
RAMA: rabbit muscle aldolase
RhuA: rhamnulose-1-phosphate aldolase
Et O CN
O CalB
ArCHO
[HCN]
AtHNL
Ar CN
OAc
AtHNL = Arabidopsis thaliana hydroxynitrile lyase
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Glossary  629 
Biocatalysis: the use of biological systems (mostly enzymes) as catalysts. Enzymes can be used as 630 
isolated proteins, crude cell-extract, or in whole cells; enzymatic preparations are often utilized as free 631 
or immobilized. Biocatalysis has widened its scopes and relevance owing to the development of different 632 
biotechnological techniques which allow for the production of satisfactory amounts of robust and 633 
selective enzymes.  634 
Flow chemistry: chemical reactions performed in a continuous flow stream. Reactants are pumped at 635 
known flow rates from reservoirs into a reactor where the chemical reaction takes place as flow runs 636 
through the reactor. 637 
Green chemistry: is directed towards the development of chemical processes that reduce waste, 638 
conserve energy, and replace hazardous reagents and solvents with renewable substances. Paul Anastas 639 
and John Warner outlined 12 rules that would make green(er) a chemical process, concerning prevention, 640 
atom economy, less hazardous chemical syntheses, designing safer chemicals, safer solvents and 641 
auxiliaries, design for energy efficiency, use of renewable feedstocks, reduce derivatives, catalytic 642 
reagents vs stoichiometric reagents, design for degradation, real-time analysis for pollution prevention, 643 
inherently safer chemistry. 644 
Packed bed reactors (PBRs): also known as fixed bed reactors, consist of a tube, filled with particulate 645 
biocatalyst (immobilized enzyme/cells) that remains in fixed positions relative to one another, as reaction 646 
medium is fed at either the top or the bottom of the column used, to form a continuous liquid phase 647 
between the particles. Screens placed on the liquid outlet to prevent the biocatalyst from leaving the 648 
column. The reaction medium must be free of solids to prevent clogging the bed. In conventional PBRs 649 
high flow rates may be required to ease mass transfer from the liquid medium to the solid catalyst, but 650 
this may lead to high pressure drop. If a PBR is operated in upflow mode at high liquid flow rates, the 651 
particles become suspended in the liquid and move about constantly. The outcome is a fluidized bed 652 
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reactor where, due to the movement of the particles, clogging of the bed and channeling (maldistribution 653 
of the flow) that may occur in PBR are avoided. Axial dispersion is significant in fluidized beds unlike 654 
PBR, hence the latter is closer to the PFR model. 655 
Plug flow reactor (PFR): a cylindrical, fully segregated flow reactor, in which the whole content is 656 
radially mixed at any given location along the reactor length (flow direction), and no mixing occurs along 657 
the direction of flow. Concentration and temperature gradients are therefore absent in the radial direction 658 
and considered in one spatial dimension, i.e., the distance along the reactor length. In this ideal steady-659 
state reactor, the residence time (τ) in the reactor is the same for all elements of fluid, as the fluid velocity 660 
is alike from the wall to the centerline of the reactor and it is determined by the flow rate (f) applied in a 661 
reactor of fixed volume. In practice, as a result of velocity variations (parabolic profile at low Reynolds 662 
number), molecular diffusion and turbulent diffusion (at high Reynolds number) some elements of fluid 663 
will reside longer in the reactor than others, promoting axial dispersion and interaction between reacted 664 
and unreacted elements of the feed (backmixing). These reactors can operate with downflow, upflow and 665 
horizontal feed of the fluid. Fluid dynamics in microreactors closely resemble the PFR model. The 666 
continuous stirred tank reactor (CSTR, also called back-mix reactor) also features continuous input and 667 
output of material and steady state. However, the contents in a CSTR are perfectly mixed, hence, the 668 
concentrations and temperature are identical anywhere inside the reactor and in the exit stream. 669 
Therefore, the reactor size for similar conversion will be smaller for PFR as compared to CSTR. On the 670 
other hand, CSTR is preferred for reactions involving substrate inhibition. In real CSTR, pockets of 671 
stagnant zones may occur, ultimately resulting in an overall conversion in the outlet lower than ideally 672 
predicted.  673 
 674 
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Pressure drop: the pressure decrease observed between the two ends (length) of the channel. It results 675 
from the Navier-Stokes equation when the pressure forces balance the viscous forces. For steady-state 676 
laminar flow of a non-compressible fluid with viscosity µ, the pressure drop (ΔP), can be determined 677 
from the Hagen-Poiseuille equation, from the volumetric flow rate (Q) or the linear velocity (v). In a 678 
channel with circular cross section of radius r (or diameter D) and length L, this is given by: 679 
 680 
Process intensification: rational use of manufacturing and development tools that allows for an 681 
increased efficiency, yield and sustainability of manufacturing processes, enhanced applicability of 682 
hazardous reactions, and a significant reduction in the time frame of process development and time-to-683 
market. Concomitantly process intensification encompasses a marked decrease in reactor size, at least of 684 
100-fold, while complying with a given production goal. 685 
Enzymatic kinetic resolution: a process leading to the separation of enantiomers from a racemic 686 
mixture by means of an enzymatic reaction operating at different rates on the two enantiomers. Kinetic 687 
resolutions result in an enantioenriched sample of the less reactive enantiomer.    688 
	  689 
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Figure 1 captions 690 
A) Pumps: used to deliver reproducible quantities of solvents and reagents at flow rates; the usual types 691 
are piston, peristaltic, syringe or gear centrifugal pumps 692 
B) Reaction loops: used to introduce small volumes of reagents 693 
C) T-piece: primary mixing point, where reagents streams are combined 694 
D) Coil reactor: provides homogeneous mixing for the reaction 695 
E) Column reactor: packed with immobilized biocatalyst (immobilized enzymes or whole cells) 696 
F) Back pressure regulator: controls the pressure of the system 697 
G) Downstream unit: in-line analytics, work-up operations, etc. 698 
H) Syringe pumps 699 
I) Microfluidic reactors 700 
 701 
 702 
Figure 2 captions 703 
1. Free biocatalyst 704 
2. Immobilized biocatalyst in a packed bed reactor 705 
3. Biocatalyst immobilized on the inner surface of the channel  706 
4. Biocatalyst immobilized on a monolith 707 
5. Biocatalyst immobilized on a membrane 708 
6. Free biocatalyst in a l/l biphasic parallel flow stream 709 
7. Immobilized biocatalyst in a l/l biphasic flow stream 710 
8. Immobilized biocatalyst in a g/l biphasic flow stream 711 
9. Free biocatalyst in a tube-in-tube reactor 712 
